|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- But Not of IFN-
-Induced JAK/STAT Pathway in a Subset of U937 Clones Prevents the Antiretroviral Effect of IFN-
Against HIV-11

*
AIDS Immunophatogenesis Unit, San Raffaele Scientific Institute, Milan, Italy; and
Department of Clinical and Biological Sciences, University of Torino, Orbassano, Italy
IFN-
induces transcription of several IFN-stimulated genes
(ISGs). Recently, the IFN-
-dependent Janus kinase (JAK)/STAT pathway
has been shown to mediate the activation of some ISGs, by the
sequential phosphorylation of two JAK kinases (JAK1 and JAK2) and of
STAT1. Given that the JAK/STAT is the major, but not the only pathway
linked to the IFN-
R, aim of our work was to investigate the
signal-transduction pathway(s) by which IFN-
exerts its effects on
acute replication of HIV in monocytic cells. To this end, we utilized
clones previously derived from the U937 promonocytic cell line,
differing for their efficient (plus clones) or inefficient (minus
clones) abilities of supporting HIV replication. Unlike IFN-
,
IFN-
did not inhibit HIV replication in plus clones, whereas virus
production in minus cells was efficiently inhibited by both types of
IFN. Plus clones generated a JAK/STAT signal-transduction pathway in
response to IFN-
, but not IFN-
. In contrast, minus clones
responded to either cytokines. The functional defect of plus clones in
response to IFN-
was correlated to a selective defect of IFN-
R2,
but not IFN-
R1, membrane expression. Surprisingly enough, IFN-
stimulation of plus clones induced IFN-stimulated gene factor 3
(ISGF3
). These results strongly support the hypothesis that the
JAK/STAT pathway is responsible for the antiretroviral effect of
IFN-
, and further provide evidence for a potential second pathway
triggered by IFN-
in the absence of IFN-
R2 chain cell surface
expression and involving ISGF3
.
This article has been cited by other articles:
![]() |
A. Crotti, M. Lusic, R. Lupo, P. M. J. Lievens, E. Liboi, G. D. Chiara, M. Tinelli, A. Lazzarin, B. K. Patterson, M. Giacca, et al. Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression Blood, June 15, 2007; 109(12): 5380 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cassol, M. Alfano, P. Biswas, and G. Poli Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence J. Leukoc. Biol., November 1, 2006; 80(5): 1018 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stitz, P. O. Krutzik, and G. P. Nolan Screening of retroviral cDNA libraries for factors involved in protein phosphorylation in signaling cascades Nucleic Acids Res., February 24, 2005; 33(4): e39 - e39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alfano, N. Sidenius, F. Blasi, and G. Poli The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 750 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Magnani, E. Balestra, A. Fraternale, S. Aquaro, M. Paiardini, B. Cervasi, A. Casabianca, E. Garaci, and C.-F. Perno Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression J. Leukoc. Biol., November 1, 2003; 74(5): 764 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-l. Huang, R. Pawliczak, X.-l. Yao, M. J. Cowan, M. T. Gladwin, M. J. Walter, M. J. Holtzman, P. Madara, C. Logun, and J. H. Shelhamer Interferon-gamma Induces p11 Gene and Protein Expression in Human Epithelial Cells through Interferon-gamma -activated Sequences in the p11 Promoter J. Biol. Chem., March 7, 2003; 278(11): 9298 - 9308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kohler, D. L. Tuttle, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages J. Leukoc. Biol., March 1, 2003; 73(3): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Losana, C. Bovolenta, L. Rigamonti, I. Borghi, F. Altare, E. Jouanguy, G. Forni, J.-L. Casanova, B. Sherry, M. Mengozzi, et al. IFN-{gamma} and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes J. Leukoc. Biol., October 1, 2002; 72(4): 735 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alfano, N. Sidenius, B. Panzeri, F. Blasi, and G. Poli Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication PNAS, June 25, 2002; 99(13): 8862 - 8867. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L.-Y. Chang, A. Mosoian, R. Pine, M. E. Klotman, and J. P. Moore A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation J. Virol., January 15, 2002; 76(2): 569 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goodbourn, L. Didcock, and R. E. Randall Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol., October 1, 2000; 81(10): 2341 - 2364. [Full Text] |
||||
![]() |
L. Rigamonti, S. Ariotti, G. Losana, R. Gradini, M. A. Russo, E. Jouanguy, J.-L. Casanova, G. Forni, and F. Novelli Surface Expression of the IFN-{gamma}R2 Chain Is Regulated by Intracellular Trafficking in Human T Lymphocytes J. Immunol., January 1, 2000; 164(1): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bovolenta, L. Camorali, A. L. Lorini, G. Vallanti, S. Ghezzi, G. Tambussi, A. Lazzarin, and G. Poli In Vivo Administration of Recombinant IL-2 to Individuals Infected by HIV Down-Modulates the Binding and Expression of the Transcription Factors Ying-Yang-1 and Leader Binding Protein-1/Late Simian Virus 40 Factor J. Immunol., December 15, 1999; 163(12): 6892 - 6897. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bovolenta, L. Camorali, A. L. Lorini, S. Ghezzi, E. Vicenzi, A. Lazzarin, and G. Poli Constitutive Activation of STATs Upon In Vivo Human Immunodeficiency Virus Infection Blood, December 15, 1999; 94(12): 4202 - 4209. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |